Crosstalk between UPR and mitochondria: The triad of ER–mitochondria contacts, Ca²⁺, and ROS
Pharmacological Research · 2026
DOI: 10.1016/j.phrs.2026.108428 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2026. Verfasst von Ester Zito und 1 weiteren Autor:innen. Beteiligte Einrichtung: Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Ital…. Hauptthemen laut MEDLINE: Mitochondria, Endoplasmic Reticulum, Unfolded Protein Response, Reactive Oxygen Species. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health Blueprint for Neuroscience Research, Telethon Foundation, National Institutes of Health.
Abstract (Originalsprache)
Endoplasmic reticulum (ER) stress is triggered by several cellular perturbations causing protein misfolding, and activates the unfolded protein response (UPR), an initially adaptive signaling network that aims to restore ER and cellular homeostasis. Growing evidence indicates that UPR signaling extends beyond ER proteostasis, influencing mitochondrial function and bioenergetics through ER-mitochondria contact sites (ERMCs). The CHOP-ERO1A-IP3R axis has a primary role in recruiting mitochondria to adaptive UPR. However, its sustained activation renders UPR signaling maladaptive, leading to mitochondrial dysfunction through both outer mitochondrial membrane permeabilization (OMMP) and mitochondrial permeability transition pore (mPTP) opening, ultimately contributing to irreversible cell injury and disease pathogenesis. Here, we examine the molecular mechanisms that govern adaptive and maladaptive UPR signaling and discuss how these ER-centered responses impinge on mitochondrial and cellular physiology. We analyze three major drivers of coupling mitochondrial function to UPR signaling: (i) enhanced ERMCs, (ii) IP3R-mediated Ca²⁺ transfer from the ER to mitochondria, and (iii) bidirectional ROS/H₂O₂ exchange between the two organelles. We also discuss unresolved questions in the field and technological advances, including approaches to investigate ERO1-dependent redox nanodomains, ERO1 inhibitors and engineered ERMC linkers, that are advancing our understanding of ER-mitochondria crosstalk and revealing potential therapeutic opportunities. These insights may inform precision medicine strategies for diseases driven by chronic ER stress and mitochondrial dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy. Electronic address: ester.zito@marionegri.it.
- Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: gyorgy.hajnoczky@jefferson.edu.
Förderung
- National Institutes of Health Blueprint for Neuroscience Research
- Telethon Foundation
- National Institutes of Health
- Associazione Italiana per la Ricerca sul Cancro
- AIRC Foundation for Cancer Research
Zitieren
APA
Zito, E., & Hajnóczky, G. (2026). Crosstalk between UPR and mitochondria: The triad of ER–mitochondria contacts, Ca²⁺, and ROS. Pharmacological Research. https://doi.org/10.1016/j.phrs.2026.108428
Vancouver
Zito E, Hajnóczky G. Crosstalk between UPR and mitochondria: The triad of ER–mitochondria contacts, Ca²⁺, and ROS. Pharmacological Research. 2026. doi:10.1016/j.phrs.2026.108428
BibTeX
@article{Zito2026,
author = {Zito, Ester and Hajnóczky, György},
title = {Crosstalk between UPR and mitochondria: The triad of ER–mitochondria contacts, Ca²⁺, and ROS},
journal = {Pharmacological Research},
year = {2026},
doi = {10.1016/j.phrs.2026.108428}
}
EUVIMED